Session Details

S055 What’s Hot in Autoimmune Connective Tissue Disease

Mon, Mar 22, 1:00 PM - 4:00 PM
3 CME Available Symposium

DESCRIPTION

Using clinical cases, classic and atypical presentations of cutaneous manifestations of autoimmune connective tissue diseases will be emphasized. This session will offer practical tips for diagnosis, appropriate evaluation, and advanced therapeutic management of patients with connective tissue diseases affecting the skin. Audience self-assessment will be encouraged through image review, and a case-based approach will be utilized to highlight relevance for the dermatology trainee or experienced clinician. Cases discussed will include those focusing on dermatomyositis, cutaneous lupus erythematosus, systemic sclerosis, eosinophilic fasciitis, and morphea, amongst others.

LEARNING OBJECTIVES

1.

Identify and diagnose classic and atypical presentations of cutaneous manifestations of autoimmune connective tissue diseases.

2.

Select management options for skin involvement in complex connective tissue diseases based on the best available evidence from the literature.

SCHEDULE

1:00 PM

Cases: What's Hot in Autoimmune Connective Tissue Disease

DIRECTOR

Ruth Ann Vleugels, MD, MBA, MPH, FAAD

Ruth Ann Vleugels, MD, MBA, MPH, FAAD

Penn Medicine

SPEAKERS

Rochelle Castillo, MD, MS

Rochelle Castillo, MD, MS

Janis Chang, MD

Janis Chang, MD

Sung Kyung Cho, MD

Sung Kyung Cho, MD

Gabriela Andrea Cobos, MD, FAAD

Gabriela Andrea Cobos, MD, FAAD

Yoo Jung Kim, MD, FAAD

Yoo Jung Kim, MD, FAAD

Daniel Mazori, MD, FAAD

Daniel Mazori, MD, FAAD

Michelle Min, MD, MSc, FAAD

Michelle Min, MD, MSc, FAAD

Joshua Prenner, MD, FAAD

Joshua Prenner, MD, FAAD

University of Pennsylvania

Kathryn Rentfro, MD, FAAD

Kathryn Rentfro, MD, FAAD

Neda Shahriari, MD, FAAD

Neda Shahriari, MD, FAAD

Leila Shayegan, MD, FAAD

Leila Shayegan, MD, FAAD

Lahey Clinic, Boston Children's Hospital

DISCLOSURES

Rochelle Castillo, MD, MS

Johnson & Johnson Innovative Medicine – Advisory Board(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Fees);

Janis Chang, MD

No financial relationships exist with ineligible companies.

Gabriela Andrea Cobos, MD, FAAD

AbbVie – Speaker(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biogen – Investigator(Honoraria); Bristol Myers Squibb – Speaker/Faculty Education(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria); Dermira/Lilly – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); Incyte – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Speaker(Fees); Octapharma – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Advisory Board(Fees), Speaker(Fees); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Fees); UCB – Advisory Board(Honoraria);

Yoo Jung Kim, MD, FAAD

No financial relationships exist with ineligible companies.

Daniel Mazori, MD, FAAD

Veradermics – Advisory Board(Fees);

Michelle Min, MD, MSc, FAAD

Amgen – Investigator(Grants/Research Funding); AstraZeneca – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Bristol Myers Squibb – Advisory Board(Other Financial Benefit), Investigator(Grants/Research Funding); McGraw-Hill Companies – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Investigator(Grants/Research Funding);

Joshua Prenner, MD, FAAD

Priovant Therapeutics – Consultant (1099 relationship)(Fees);

Kathryn Rentfro, MD, FAAD

No financial relationships exist with ineligible companies.

Neda Shahriari, MD, FAAD

AbbVie – Consultant (1099 relationship)(Honoraria); AstraZeneca – Investigator(Grants/Research Funding); Biogen – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Incyte – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant (1099 relationship)(Honoraria);

Leila Shayegan, MD, FAAD

Priovant Therapeutics – Consultant (1099 relationship)(Fees);

Ruth Ann Vleugels, MD, MBA, MPH, FAAD

AbbVie – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); Biogen – Consultant (1099 relationship)(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);